Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

HBI News Round Up, Friday 30th August 2024

In this HBI News Round Up we cover the investment summary of pan-European firm Affidea's Romanian branch the first half of 2024, global leader in RNA-based genomic diagnostics BioNexus Gene Lab Corp’s investment into a pioneering Malaysian healthcare technology firm, Ascension Innovation Sdn Bhd, and Portuguese hospital group CUF's profits results for the first half of 2024.
August 30, 2024

Accenture to expand healthcare capabilities in Germany with acquisition of consus.health

Tech consultancy firm Accenture is going to expand its healthcare capabilities in Germany with the acquisition of leading German healthcare management consultancy, consus.health. The details of the acquisition, which is expected to complete subject to customary closing conditions, were not disclosed. Freiburg im Breisgau-based consus.health was founded in 2012 and has more than 600 healthcare […]
August 29, 2024

Mubadala and CBC Group acquire Belgian biopharma UCB’s China operations

UCB, a Belgian biopharma company, plans to divest its business in China, to CBC Group, a Singapore-based investment firm, and Mubadala, a global investment company from Abu Dhabi, for $680 million.  The deal, pending regulatory approval, is expected to close in Q4 2024 and includes UCB’s neurology and allergy portfolios, as well as its manufacturing site in Zhuhai, China.
August 29, 2024

UK launches £400 million public-private partnership to address critical need in pharmaceutical testing

The UK’s Department of Health and Social Care (DHSC), NHS England, and the Association of the British Pharmaceutical Industry (ABPI) have launched a £400 million initiative to improve the country’s pharmaceutical testing capabilities. Termed the ‘Voluntary Scheme for Branded Medicine Pricing, Access and Growth’ (VPAG), this public-private investment will create up to 18 new clinical trial hubs across the UK, speeding up the development and availability of new medicines, as detailed in the August 28 press release.
August 29, 2024

PAI Partners seeks sovereign wealth fund boost for Sanofi consumer healthcare bid

PAI Partners, the French private equity firm, is in talks with two of the world's largest sovereign wealth funds to support its offer for Sanofi SA's consumer health division. According to anonymous Bloomberg sources, the Abu Dhabi Investment Authority (ADIA) and Singapore's GIC Pte are considering joining PAI's consortium. The deal could value the business […]
August 29, 2024

Hillhouse and EQT vie to acquire global BPO provider GeBBS

The sale of US-based healthcare BPO firm GeBBS Healthcare Solutions has entered its final stage, with Asian and European funds competing for acquisition. Hong Kong’s Hillhouse Investment has emerged as the frontrunner and is reported to have offered approximately USD $870 million for a 100% stake, slightly ahead of Sweden’s EQT Partners' bid of $855-860 […]
August 29, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us